Presenter Details

Michael Vidne
Michael Vidne

he joining bringing in to experience Applied high-tech industries. and system to visual semiconductor Vidne his and mainly NovellusDx, research Prior in in and management University mathematical McKinsey with 2013, Dr. in was populations. the both Co. US Columbia serving Office, him neuron joined 2011, & consultant in the machine the with received where methods Coast mammalian NovellusDx learning a Ph.D. and West statistical Vidne Mathematics analysis. Michael from Dr. employed

topic-arrow Presenter for:
Hall M
Thursday - October 18, 2018
02:00 PM
02:45 PM

Using Deep Learning to Predict Activity and Drug Response of Unknown Mutations

By applying deep learning to images of mutated cells interacting with drugs, we can predict how cells with unknown mutations respond to these drugs. State-of-the-art cancer treatment starts with sequencing a tumor biopsy. Alas, we don't know how most mutations act or respond to drugs. Therefore, the treating physician cannot integrate this data into the treating protocol. To solve this, ...

View Abstract Full Abstract

AI in Healthcare